Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis

Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shioya, Nobuki, Inoue, Nozomu, Sato, Hiroki, Iwahara, Motoko, Sato, Tomohiro, Tsukamoto, Yuki, Naito, Yuki, Hazama, Kohji, Shichinohe, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314566/
https://www.ncbi.nlm.nih.gov/pubmed/35903505
http://dx.doi.org/10.1002/ccr3.6140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314566/
https://www.ncbi.nlm.nih.gov/pubmed/35903505
http://dx.doi.org/10.1002/ccr3.6140

Ejemplares similares